Joffe B I, Panz V R, Wing J R, Raal F J, Seftel H C
Department of Medicine, University of the Witwatersrand Medical School, Parktown, Johannesburg, South Africa.
Lancet. 1992 Aug 22;340(8817):460-2. doi: 10.1016/0140-6736(92)91777-6.
Non-insulin-dependent diabetes mellitus (NIDDM) is an important health problem in the black population of southern Africa. Whether the primary cause of NIDDM is insulin secretory dysfunction or peripheral insulin resistance is unknown. In westernised populations it is believed that insulin resistance and hyperinsulinaemia occur in the early stages of disease, followed later by progressive impairment of insulin secretion. However, we suggest that in the southern African black population a decrease in the mass of functioning beta cells is an important event, making these people vulnerable to the deleterious effects of insulin resistance induced by obesity and other factors. These abnormalities are, in turn, associated with insulin receptor down-regulation. An accelerated decline in beta-cell function then follows in susceptible individuals, ultimately producing striking insulinopenia. Insulinopenic NIDDM in black southern Africans may partly explain why this population has a comparatively low incidence of macrovascular complications and also predicts a short-lived therapeutic response to oral sulphonylureas in most patients.
非胰岛素依赖型糖尿病(NIDDM)是南部非洲黑人人群中的一个重要健康问题。NIDDM的主要病因是胰岛素分泌功能障碍还是外周胰岛素抵抗尚不清楚。在西方化人群中,人们认为胰岛素抵抗和高胰岛素血症在疾病早期出现,随后胰岛素分泌逐渐受损。然而,我们认为在南部非洲黑人人群中,有功能的β细胞数量减少是一个重要因素,使这些人易受肥胖和其他因素诱导的胰岛素抵抗的有害影响。这些异常反过来又与胰岛素受体下调有关。然后,易感个体的β细胞功能加速下降,最终导致明显的胰岛素缺乏。南部非洲黑人中的胰岛素缺乏型NIDDM可能部分解释了为什么该人群大血管并发症的发病率相对较低,并且还预示着大多数患者对口服磺脲类药物的治疗反应短暂。